Investigators conclude that microarray-generated cell cycle progression score should not be assumed to be a valid surrogate for qRT-PCR-generated scores.
Single-dose disposable auto injector approved for once-weekly subcutaneous administration of testosterone may cut down on potential problems associated with other options.
Promising results from clinical trials could encourage urologists to offer immunotherapy to their bladder cancer patients.
Delivering care at a distance may enable practices to expand their current geographic boundaries and enhance patient satisfaction.
Active involvement in the digital ecosphere is vital to patient engagement.
A multiplex polymerase chain reaction assay detected bacteria species missed by traditional urine culture as well as more fastidious bacteria.
Chicago urologist Richard Harris, MD, says one of the biggest challenges facing independent urology practices is the constantly changing Medicare rules and regulations.
The LUGPA 2018 Annual Meeting will take place from November 1-3, 2018, in Chicago, Illinois.
Desmopressin orally disintegrating tablets resulted in declines in nocturnal voids in men and women with nocturnal polyuria and mild daytime voiding dysfunction.
In a study, 28% of all incident in-hospital falls were associated with nighttime visits to the toilet.
LUTS treatment with the alpha-blocker prazosin was associated with significantly lower 2- and 5-year biochemical recurrence rates vs tamsulosin and non-use of alpha-blockers.
Phase 4 trial showed that mirabegron significantly decreased incontinence episodes and micturitions compared with placebo among patients aged 65 years and older.
A study of commercially insured patients showed Asians and Hispanics were less likely than whites to undergo advanced overactive bladder treatments.
Even modestly elevated fasting plasma glucose levels and HbA1c is associated with increased odds of overactive bladder.
The ratio of visceral fat volume to total abdominal fat volume is an independent risk factor for overactive bladder, study finds.
German study revealed a 13% higher risk of falls among patients with vs without nocturia.
Of patients who had transient stress urinary incontinence after holmium laser enucleation of the prostate, 88.6% experienced resolution of the incontinence within 6 weeks after the procedure.
An expert panel developed a framework of 22 nocturia phenotypes that could set the stage for devising diagnostic and treatment pathways and stimulating research.
Canadian study documents a fall in the annual rate of transvaginal sling procedures for female stress incontinence after 2009.
Among patients with detrusor underactivity, 14% of women had neuropathic causes compared with only 2% of men.
Nearly 55% of men with lower urinary tract symptoms suffer from nocturnal polyuria, according to a study conducted in Italy.
Mirabegron use for overactive bladder rose to 16% in 2016, whereas anticholinergic use decreased to 78% in 2016 from 97% in 2003, a study found.
In a phase 2 trial, treatment with an acetaminophen-ibuprofen combination was associated with a significant reduction in nocturnal voids and improved quality of life compared with placebo.
Clinicians can rest easier about recommending finasteride to more men, according to experts.
In 2015, 69% of surgeries for prostate, bladder, and kidney cancer were performed with robotic assistance, a new meta-analysis shows.
Real-world study confirms the improved sensitivity of blue light vs white light cystoscopy (91% vs 79%) for detecting bladder cancer.
Men with low-risk PCa who underwent partial gland ablation with vascular-targeted photodynamic therapy were less likely than those on AS to require radical treatment.
The percentage of prostate cancer patients with positive lymph nodes increased from 2.4% in 2010 to 4.7% in 2014.
Uric acid and struvite stones are more likely to recur than calcium oxalate stones, according to a study.
The procedure improves symptoms at least as well in men with obstructive middle lobes as those with obstructive lateral lobes.
Renal and Urology News Articles
- Pembrolizumab Shows Promise for BCG-Unresponsive Bladder Cancer
- Radical Cystectomy Superior to Trimodal Therapy for Muscle-Invasive Bladder Cancer
- Dialysis and Transplant Patients at Increased Risk for Cancer Death
- Tivozanib Offers Superior Outcomes in Refractory Metastatic Renal Cell Carcinoma
- Radiation, Chemotherapy Not Beneficial in Localized Upper Tract Urothelial Carcinoma
Sign Up for Free e-newsletters
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)